Microneedling for the Treatment of Acne Scars: A Scoping Review of Therapeutic Protocols, Combination Therapies, and Current Evidence
Journal of Cosmetic Dermatology · 2026-11 · 25 (11)
DOI: 10.1111/jocd.71285 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 11.11.2026. Verfasst von Luca Castellano und 4 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives Atrophic acne scarring is a complex condition with no definitive single treatment. Microneedling (MN) is a safe alternative to ablative procedures because it preserves the epidermis, minimizing the risk of post‐inflammatory hyperpigmentation. This scoping review maps the available literature on the technical parameters, multimodal protocols, and knowledge gaps associated with mechanical MN for acne scar revision.
Methods
Following JBI and Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews (PRISMA‐ScR) guidelines, a systematic search was conducted across PubMed and Scopus for English‐language articles published over the last decade. Both primary clinical research and secondary evidence syntheses evaluating manual and motorized mechanical MN were included.
Results
A total of 85 studies met the inclusion criteria. Extracted data reveal a dichotomy between manual dermarollers and motorized pens, with penetration depths ranging from 0.5 to 3.0 mm. Because MN monotherapy shows limited efficacy for complex lesions, current protocols have shifted clearly toward multimodal regimens. MN is frequently combined with surgical subcision, chemical peels, and transdermal agents. Platelet‐Rich Plasma (PRP) is the most widely utilized adjunct, while topical human insulin is emerging as a promising alternative.
Conclusions
The mapped evidence supports MN as a safe bridging intervention for multimodal scar management. However, this review identifies a critical methodological gap: the pervasive reliance on truncated follow‐up periods (1 to 3 months). This abbreviated timeline predominantly captures transient inflammatory edema rather than definitive neocollagenesis, risking an overestimation of long‐term efficacy. Future clinical trials must implement a minimum follow‐up of 6 to 12 months alongside objective biometric assessments.
Zitieren
APA
Castellano, L., Capponi, A., Rovatti, P. P., Campomagnani, E., & Maccari, I. (2026). Microneedling for the Treatment of Acne Scars: A Scoping Review of Therapeutic Protocols, Combination Therapies, and Current Evidence. Journal of Cosmetic Dermatology, 25(11). https://doi.org/10.1111/jocd.71285
Vancouver
Castellano L, Capponi A, Rovatti PP, Campomagnani E, Maccari I. Microneedling for the Treatment of Acne Scars: A Scoping Review of Therapeutic Protocols, Combination Therapies, and Current Evidence. Journal of Cosmetic Dermatology. 2026;25(11). doi:10.1111/jocd.71285
BibTeX
@article{Castellano2026,
author = {Castellano, Luca and Capponi, Angela and Rovatti, Pier Paolo and Campomagnani, Elisa and Maccari, Ilaria},
title = {Microneedling for the Treatment of Acne Scars: A Scoping Review of Therapeutic Protocols, Combination Therapies, and Current Evidence},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {11},
doi = {10.1111/jocd.71285}
}
EUVIMED